TOPK Inhibition Promotes Anti‐Tumor Immunity Via eIF4F Complex Mediated STAT1 Translation in Gastric Cancer
Open Access
- 19 December 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (13) , e17380
Abstract
Immune checkpoint blockade‐directed immunotherapy emerges as a revolutionary therapy in gastric cancer (GC). However, the proportion of patients who can benefit from it and its overall efficacy remain limited. Here the aim is to identify key dual‐function targets that both inhibit proliferation and suppress immune evasion. Using whole genome‐wide CRISPR‐Cas9‐based screening, the serine/threonine kinase T‐lymphokine‐activated killer cell‐originated protein kinase (TOPK) is identified as a key regulator of PD‐L1 in gastric cancer upon IFN‐γ stimulation. Mechanical study is performed to explore the role of TOPK in promoting GC malignancy and immune evasion in vitro and vivo. Higher TOPK levels in tumor tissues are observed, correlated with clinical stages, efficacy and survival. Upon IFN‐γ stimulation, TOPK phosphorylates eIF4F complex component eIF4A1 to increase its unwinding activity of STAT1 mRNA, enhancing STAT1 translation efficiency. This process leads to adaptive overexpression of PD‐L1 and IDO1, resulting in immunometabolic suppression through PD‐L1‐mediated inhibition, IDO1‐induced tryptophan depletion and kynurenine production. TOPK inhibitors reshape tumor immunometabolic microenvironment to trigger anti‐tumor immunity in GC. The IFN‐γ‐TOPK‐eIF4F‐STAT1‐PD‐L1/IDO1 axis as a crucial regulator of the tumor immunometabolic microenvironment and provide novel insights into the combination of targeted therapy and immunotherapy for GC treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82573666)
- National Natural Science Foundation of China (82573870)
- National Natural Science Foundation of China (82473157)
- National Natural Science Foundation of China (82272889)
- National Natural Science Foundation of China (82203579)
- Natural Science Foundation of Beijing Municipality (7222023)
- Natural Science Foundation of Beijing Municipality (L248059)
- China Postdoctoral Science Foundation (2025M772256)
This publication has 48 references indexed in Scilit:
- Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironmentCancer Cell, 2024
- Predictive biomarkers in gastric cancerJournal of Cancer Research and Clinical Oncology, 2022
- Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growthCancer Letters, 2022
- Targeting protein kinases benefits cancer immunotherapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cellsBiochemical Pharmacology, 2022
- PBK promotes aggressive phenotypes of cervical cancer through ERK/c‐Myc signaling pathwayJournal of Cellular Physiology, 2020
- Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcomaJournal of Cancer Research and Clinical Oncology, 2020
- EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactionsGastric Cancer, 2018
- IFN-γ and tumor gangliosides: Implications for the tumor microenvironmentCellular Immunology, 2018
- Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung CancerCell Reports, 2017